Trade Summary

2 days ago, Lee Sung, serving as EVP, Chief Financial Officer at CYTOKINETICS INC (CYTK), sold 3,134 shares at $85.00 per share, for a total transaction value of $266,390.00. Following this transaction, Lee Sung now holds 63,221 shares of CYTK.

This sale represents a 4.72% decrease in Lee Sung's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 29, 2026 at 5:23 PM ET, meaning the disclosure happened on the same day as the trade.

CYTOKINETICS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.